Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.


Sheba Medical Center is working on enhancing patient safety with AI solutions.

Enhancing Patient Safety and Care with AI Solutions

With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial…
Read More
IBD passport for patients with ulcerative colitis.

Meet the IBD Passport: A New Hope for Ulcerative Colitis and Crohn’s Disease Patients 

Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating,…
Read More
Sheba Partners with Rhino Health

Sheba Partners with Rhino Health: Advancing AI, Protecting Privacy

Sheba's ARC Innovation Center and Rhino Health, developer of a federated computing platform for privacy-preserving artificial intelligence applications, announced a strategic partnership designed to accelerate…
Read More
Sheba Medical Center in Israel and CAPS Medical explore a new bladder cancer treatment.

Sheba and CAPS Medical Partner to Assess a New Bladder Cancer Treatment 

Non-muscle invasive bladder cancer (NMIBC) develops in the tissue that lines the bladder's inner surface. NMIBC is characterized by a high recurrence rate of up…
Read More
Sheba Medical Center offers a minimally invasive procedure for Micra leadless pacemaker

Sheba Has Been Designated an Official Micra Pacemaker Training Center

A pacemaker, also called a cardiac pacing device, is a small apparatus that's placed (implanted) in the chest to help control the heartbeat by sending…
Read More
clinical trial

New Hope for Peritoneal Cancer Patients

Peritoneal cancer is a rare malignancy that develops in the peritoneum, a membrane that lines the walls of the abdominal cavity and rests on the…
Read More
Aml remission possible with Zantrene as part of medication regimen.

Zantrene May Promote Long-term Remission in  Acute Myeloid Leukemia Patients, Sheba Study Indicates

Zantrene, also known by its generic name bisantrene dihydrochloride, is an anti-cancer drug used both as a low-dose targeted precision oncology agent as well as…
Read More
Maria’s Story of Adversity

Maria’s Story of Adversity and Hope

After developing a fever, 4-year-old Maria was brought to the hospital in her native Cyprus by her parents, Nikolas and Ioana. Doctors diagnosed her with…
Read More
Lung Cancer

Study of Human Lymphocyte Antigen Peptides Reveals New Possible Lung Cancer Treatments

Headed by Dr. Michael Peled, researcher and attending physician at Sheba’s Institute for Pulmonary Medicine, and Prof. Arie Admon of the Technion – Israel Institute…
Read More